-Peptidyl arginine deiminase 2 (PADI2) deiminates arginine (R1810) present at Cterminal domain of RNA polymerase II (RNAP2-CTD).
Summary
The C-terminal domain of the large subunit of RNA polymerase II (RNAP2-CTD) coordinates transcription and associated processes by acting as a landing platform for a variety of protein complexes. In mammals, the RNAP2-CTD comprises 52 heptapeptide repeats, the first half of which exhibit the consensus repeat sequence Y 1 -S 2 -P 3 -T 4 -S 5 -P 6 -S 7 , whereas the second half (28-52) contains deviations from this consensus [1] [2] [3] . The residues present on CTD undergo posttranslational modifications to determine which factors will be recruited to process nascent transcripts and modify chromatin. Dynamic phosphorylation, mainly on serines 2 and 5 mediates selective recruitment of protein complexes [4] [5] [6] [7] , but recently, modifications of lysines and arginines in non-consensus repeats have expanded the functional complexity of the CTD code [8] [9] [10] [11] . Here we show that R1810 can be deiminated by PADI2 favoring RNAP2 pause release at highly expressed genes relevant for proliferation of breast cancer cells. Depletion of PADI2 reduced expression of these genes accompanied by accumulation of RNAP2 at transcriptional start sites and resulted in inhibition of cell proliferation. As PADI2 is overexpressed in several cancers and is related to poor prognosis, selective inhibitors may help to prevent cancer progression.
Deimination of R1810 at RNAP2-CTD
Arginine deimination, also known as citrullination, is a post-translational modification of arginine residues that generates the non-coded amino acid citrulline. This reaction is catalyzed by enzymes called peptidyl arginine deiminases (PADIs) [12] [13] [14] . Arginine 1810 in repeat 31 can be asymmetrically 10 or symmetrically 11 dimethylated leading to reduced expression of small nuclear and nucleolar RNAs 10 , or facilitating transcription termination 11 , respectively. We explored the possibility that it could be deiminated and functionally affect the transcription. Immunoprecipitation from nuclear extracts of the breast cancer cell line T47D-MTVL 15 using an α-citrulline detects two bands migrating as the non-phosphorylated (IIA) and week phosphorylated (IIO) forms of the large subunit of RNAP2 (Fig.1a) . The IIO form reacted with α-citrulline to much higher proportion than IIA form of RNAP2. Next, we raised a specific antibody against a 13 residues peptide centered on R1810, which was replaced by citrulline (Extended Data Fig.1a ). To validate that R1810 is deiminated, we transiently transfected T47D-MTVL cells with α-amanitin resistant HA-tagged wild type (WT r ) or R1810A r mutant of RNAP2, followed by α-amanitin treatment to deplete the endogenous RNAP2 (Extended Data Fig.1c-d) .
Precipitation with anti-HA antibody followed by Western blot showed that the WT r RNAP2, but not the R1810A r mutant, reacts with α-Cit1810 (Fig.1b) . In super-resolution immunofluorescence images of T47D cells, α-Cit1810 decorated bright clusters overlapping with RNAP2, preferentially in its S2 or S5 phosphorylated forms (Extended Data Fig.1e-f ).
PADI2 deiminates R1810 at RNAP2-CTD
Searching for the responsible enzyme, we found that T47D cells express only Padi2 and with S5P and S2P-RNAP2 (Fig.1g, Extended Data Fig.2f ). Precipitation with monoclonal antibodies against RNAP2 phosphorylated at S2 and S5 (see methods) pulled down Cit1810 RNAP2 as well as PADI2 but not PADI3 (Fig.1h) , suggesting an association of PADI2 with the active RNAP2. T47D nuclear extracts fractionated by size exclusion chromatography separated PADI2, along with phosphorylated RNAP2, in the high molecular weight fractions not PADI3 (Extended Data Fig.2g ). Triple labeling immunofluorescence showed that PADI2 co-localized with Cit1810-RNAP2 and with S2P-RNAP2, consistent with PADI2 being an integral part of the engaged RNAP2 transcription machinery (Extended Data Fig.2h ).
PADI2 is required for transcription regulation in breast cancer cells
To understand the function of PADI2, we performed replicated mRNA sequencing in wild type and PADI2-depleted T47D cells (Extended Data Fig.3a ). PADI2 knockdown affected over 4,000 genes ( on transcription, we performed chromatin-RNA sequencing 19, 20 (ChrRNA-seq) and found that ~2,000 genes were significantly affected by PADI2 knockdown, the majority of them (1, 884) were down-regulated and 20% of them were significantly reduced at mRNA seq ( Fig.2d-f ). We substantiated expression of PADI2-dependent genes through RT-qPCR on ChrRNA (Fig.2g) . Thus, PADI2 favors transcription at the level of chromatin associated nascent transcripts.
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PADI2 recruitment associate with RNAP2 and correlates with genes expression level
Chromatin immunoprecipitation sequencing (ChIP-seq) of PADI2 in T47D cells showed that 60% of chromatin-bound PADI2 is located over protein-coding gene sequences, within 3kb upstream of TSS (transcription start site) and 3kb downstream of TTS (transcription termination site) (q value ≤0.005). PADI2 highest enrichment (2.5-fold) was found in the coding exons, followed by the 3kb downstream of the TTS (1.6-fold) (Extended Data Fig.4a ). Overall PADI2 occupancy overlapped with RNAP2 binding measured by ChIP-seq, suggesting that PADI2 accompanies RNAP2 along the genes up to the termination region (Fig.3a) . Quartiles of increasing levels of transcription 21 showed increased occupancy of RNAP2 and PADI2 in parallel with the expression levels (Extended Data Fig.4b) . We verified the correlation of PADI2 and gene expression by ChIP-qPCR on highly expressed (Serpina6, c-Myc) and low expressed (Gstt2) genes and found that after PADI2 depletion the values decreased (Extended Data Fig.4c ). PADI2 occupancy on PADI2 dependent genes was significantly higher on genes downregulated than non-regulated by PADI2 depletion (Extended Data Fig.4d) . Additionally, RNAP2-ChIP followed by PADI2 re-ChIP revealed the association of RNAP2 and PADI2 at regulatory regions and gene bodies of the highly transcribed Serpina6, c-Myc genes, but not in the low expressed Gstt2 gene, supporting the functional association of PADI2 with the transcription machinery (Extended Data Fig.4e ).
PADI2 mediated deimination of R1810 at RNAP2-CTD is essential for pause release
Next, in RNAP2 ChIP-seq we found that T47D cells expressing the R1810A r mutant not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/216143 doi: bioRxiv preprint first posted online Nov. 8, 2017; exhibited accumulation of RNAP2 close to the TSS and increased pausing index particularly in highly transcribed genes (Fig. 3b) , confirming previous findings in Raji cells 11 . Notably, this tendency was more pronounced in PADI2 dependent genes (n=2186) (Fig. 3c-e) . Sequencing of mRNA of T47D cells expressing R1810A r mutant RNAP2
showed 1392 down-regulated genes. Of which 939 (67.4%) were also dependent on PADI2. These 939 genes showed significant higher pausing index compared to cells expressing WT r RNAP2 (Extended Data Fig.4f) , confirming a role of PADI2 and R1810
in RNAP2 pause release. in RNAP2 promoter pause release. In summary, we found that PADI2 deiminates R1810
at CTD of RNAP2 and is essential for promoter pause release of highly expressed genes required for cancer cell proliferation. Depletion of PADI2 or expression of RNAP2 carrying the R1810A r mutation leads to RNAP2 pausing along with decrease of phosphorylated RNAP2.
Discussion
The previously reported asymmetrical 10 and symmetrical 11 dimethylation of R1810 was detected only after phosphatase treatment. In contrast, R1810 deimination is preferentially found associated with the active RNAP2. Depletion of CARM1 and PRMT5 did not affect expression of PADI2 dependent genes and depletion of PADI2 did not change the expression of broad range of snRNAs, targets of arginine methylases.
Thus, it seems that R1810 methylation and deiminiation are required for different sets of genes and are largely independent processes. However, we also find genes upregulated upon PADI2 depletion or R1810A RNAP2 mutant expression in T47D cells, which exhibited lower pausing index (Extended Data Fig.5d-e) . Their upregulation could be an indirect consequence of the irreversible nature of deimination that will interfere with the role of R1810me2s on transcriptional termination 11 .
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Antibodies
Anti-CTD cit1810 Antibody
The citrulline specific antibody was raised in rabbits by Eurogentec using a KLH coupled CTD peptide sequence (YSPSSP-cit-YTPQSP). Affinity purification was performed first on a column containing the citrullinated peptide, followed by removal of noncitrullinated specific antibodies on a column containing the non-citrullinated peptide.
Commercial antibodies used in this study were as follows: anti-PADI2 for ChIP: (sc- 
Plasmids
The α-amanitin resistant HA-tagged wild type (WT r ) or R1810A r mutant RNAP2 plasmids were previously published 10,27 . The GST-N-CTD (repeats 1-25.5), the GST-C-CTD (repeats 27-52) of RNAP2 were kindly provided by David Bentley 31 .
RNA interference experiments
For siRNAs inhibition experiments T47D-MTVL or MCF7 cells were transfected with 100µM siRNA using Lipofectamine 3000 (Invitrogen) for 72 hours according to manufacturer´s instructions. SMARTpool On-target plus siRNAs for PADI2 (M-019485-01) and PADI3 (M-021051-01) were purchased from Dharmacon (Thermo Scientific).
siRNAs for CARM1 (sc-44875), PRMT5 (sc-41073) and PADI4 (sc-61283) were purchased from Santa Cruz. 
RNA extraction and RT-qPCR
abundance was calculated using the standard curve method and expressed as relative RNA abundance after normalizing against the human Gapdh gene level. All the gene expression data generated by RT-qPCR represent the average and SEM of at least 3 biological replicates. Primers used for RT-qPCR were as listed here: Complementary DNA was quantified by qPCR. Before preparing chromatin RNA libraries, 1µg of chromatin RNA was used to deplete rRNAs followed by libraries preparation using TruSeq Stranded total RNA Library Prep Kit (Illumina) and sequenced using Illumina HiSeq 2500.
Thbs1 f CAGAATGTGAGGTTTGTCTTTG
Thbs1 r TCTTGTGGCCAATGTAGTTAG
Pgr f AGGTCTACCCGCCTATCTC Pgr r GATGCTTCATCCCCACAGAT Gnmt f CCATTATGCTGGTGGAAGAG Gnmt r CATCTTTGTCCAGAGTCATCC Nfkbia f TGAGGATGAGGAGAGCTATG Nfkbia r CCTCCAAACACACAGTCATC Cald1 f AGTCCTTCCTTTCCGACTTA Cald1 r CCCTGTGGAATTTGATTTGATG not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/216143 doi: bioRxiv preprint first posted online Nov. 8, 2017; Irx2 f CTACGAGCCCAAGAAAGATG Irx2 r CACTTACTTGCATTGCTGTG Ehbp1 f CGAAGAAATGGCAACCAGATA Ehbp1 r
Protein extract preparation, Co-immunoprecipitation (IP), and Western blots
Cells were prepared as described previously 29 . Briefly, 5 x 10 6 to 10 7 cells were lysed on ice for 30 minutes in lysis buffer (1% Triton X-100 in 50mM Tris pH 7.4-7.6, 130mM
NaCl) containing proteases inhibitors (11836170001, Roche) with rotation, followed by mild sonication pulses each 10 seconds. After centrifugation at 4ºC and 13,000rpm for 10 minutes, extracts were used for protein quantitation. For IP 2mg of extract proteins were incubated for 12 hours with protein G/A agarose beads (for rabbit antibodies, IP05, Millipore) or Dynabeads (for mouse antibodies, 11201D, ThermoFisher Scientific), not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/216143 doi: bioRxiv preprint first posted online Nov. 8, 2017; previously coupled with 5-7µg of the corresponding antibodies or a control IgGs. For RNAP2-S2P and -S5P 7µg of each mouse monoclonal antibodies (CMA602 or CMA603, respectively) were coupled with Dynabeads, followed by 12 hours incubation with extract at 4ºC. The samples were washed 6 times with lysis buffer and boiled for 5 minutes in SDS gel sample buffer. For detection of mentioned proteins of molecular weight (<200 kDa) 4-12% SDS-PAGE gels were used; while for the RNAP2 large subunits (> 200kDa) we used 3-8% SDS-PAGE. For Western blots primary antibodies were used at 1:250 to 1:1000 dilution and incubated overnight at 4ºC, followed by an hour incubation with horseradish peroxidase conjugated anti-mouse (NA931V) or anti-rabbit (NA934V, Amersham) and blots were developed using ECL prime Western blotting detection reagent (RPN2232, GE Healthcare) according to the manufacture instructions.
Size exclusion chromatography
The size exclusion chromatography of T47D-MTVL cell extracts were carried out using 
Fluorescence-activated cell sorting (FACS) experiments
FACS assay was performed in T47D-MTVL cells transfected with control or PADI2
siRNAs from three biological replicates. Briefly, cells were trypsinized, washed three times with 1x PBS and fixed with cold absolute ethanol in suspension at 70% final concentration. Cells were stained with propidium iodide (P-1304, Molecular Probe) followed by DNase free RNase A (AM2222, Ambion) treatment and stored for 24 hours at 4ºC and DNA contents of cell cycle phases were analyzed using a BD™ LSR II flow cytometer.
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In vitro deimination assay with recombinant PADI2 and fragments of the RNAP2-CTD
The PADI2 open reading frame (ORF) was cloned into the HIS-tagged expression vector pCOOFY40 and the plasmid sequence were verified. Recombinant proteins were expressed in HEK-293 cells and purified following the standard method of histidinetagged recombinant protein. Briefly, cells were lysed in Buffer A (50mM Tris HCl pH7.4, 500mM NaCl, 10% glycerol, 2mM DTT, 20mM Imidazole, 1% and triton X-100) complemented with proteinase inhibitors (11836170001, Roche). Purification was performed using the HiTrap TALON crude (28953766, GE Healthcare) according to manufacturer´s instruction. Proteins eluted in buffer containing 50mM Tris-HCl pH 7.4, 300mM NaCl and 10% glycerol, were stored at -80ºC until required. The GST-N-CTD (repeats 1-25.5), GST-C-CTD (repeats 27-52) of RNAP2 were expressed and purified following the standard glutathione bead purification 28 . In vitro citrullination was carried with recombinant His-PADI2 in deimination buffer (50mM HEPES pH 7.5, 10mM
CaCl 2 , 4mM DTT) at 37 ºC for 1hour. Samples were dissolved in sample Laemmli buffer for immunoblot analysis using an anti-citrulline antibody 30,31 (Millipore,17-347).
Microscale Thermophoresis (MST 18 ) of recombinant PADI2 with RNAP2-CTD peptides
Wild type peptide or peptides carrying different modifications at R1810, S1805, S1808 and S1815 (20nM to 500µM) were titrated against a fixed concentration of fluorescent recombinant His-PADI2 (50nM). MST data were acquired at 20°C using the red LED at Differential expression analysis was performed using DESeq2 Bioconductor package 36 .
Analysis was performed by using 196,520 number of annotated transcripts of hg19 (correspond to 57,280 number of genes). Out of this, we quantitated data for total 18,241
(mRNA seq) and 33,140 (ChrRNA seq) genes. Genes with FC < 1/1.50 and adjusted pvalue < 0.01 were considered as down-regulated and genes with FC > 1.50 and adjusted p-value < 0.01 as up-regulated ( Fig. 2a and 2d ).
Gene Ontology (GO) analysis
Go Annotation were performed using the online tool GSEA 37 (Gene Set Enrichment Analysis, http://software.broadinstitute.org/gsea/index.jsp ) collection database v5 . The significant cut off p value and FDR q-value <0.05.
All 315 genes documented with the parent cell cycle GO:0007049 were considered (http://software.broadinstitute.org/gsea/msigdb/cards/CELL_CYCLE_GO_0007049) for analysis. Among them, 282 genes expressed in T47D cells; 101 genes classified as PADI2 dependent (siCtrl/siPadi2 FC < 1/1.5, p value < 0.01) and rest 181 genes as PADI2 independent (Extended Data Fig. 3g , Extended Data Table1).
Oncomine Gene Expression and mutation analysis in Cancer cohorts
PADI gene family expression was analyzed by using the using Oncomine 4.5 database (Compendia Bioscience) in breast 38-40 and other cancer cohorts 41-46 (Extended Data Table   2 ). The p-value for a gene is its p-value for the median-ranked analysis (extended data figure 6a & 6e). Padi2 and Padi3 genes expression level were analyzed in normal breast versus ductal or invasive ductal breast carcinoma cohorts (extended data figure 6b, 6d) and also in normal breast vs invasive lobular breast carcinoma cohorts (Extended Data   Fig. 6c ). Data is represented as log2 median expression in cancer versus normal.
Kaplan Meier Survival Analysis
Kaplain Meier analysis was performed using the publically available tool Kaplain Meier not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Chromatin immunoprecipitation (ChIP) and sequencing analysis
ChIP assays were performed as described previously 52 . 
PADI2 and RNAP2 ChIP purified DNA was used to prepare ChIP-seq libraries (biological replicates) and sequenced using Illumina HiSeq 2000 to obtain ~80-100 million reads per replicate. Single-ended sequences were trimmed to 50 bp and mapped to the human genome assembly hg19 using Bowtie 53 , keeping only tags that mapped uniquely and with no more than two mismatches. In both biological replicate significant enrichments compared to Input DNA (hereafter referred to as peaks) were identified using SICER 54 with the following parameters: window size 200; fragment size 233 bp ; gap size 600; and FDR 0.01. Genome-wide 10kb Spearman pairwise correlation of PADI2
ChIP-sequencing signal was R 2 =0.98 .We then applied ChIPpeakAnno R library 55 to
create a merged list of peaks present in both replicates. Fragment sizes were estimated using HOMER tools 56 , and used to extend reads towards 3' direction in order to compute genome-wide reads per million (RPM) normalized profiles. RNAP2 ChIP-seq sequences were analyzed as mentioned previously 57 . ChIP-seq RPM normalized profiles were used to generate average profiles over different genomic features using bwtool 58 .
Pausing Index (PI) of RNAP2 Analysis
RNAP2 pausing index was calculated as mentioned previously 21,59-60 . Briefly, RNAP2
pausing index represents the dynamics of RNAP2 assembly and promoter release and hence not only presence or absence of transcription. We calculated pausing index (PI) as the ratio of the RNAP2 read count 1kb (kilo base) flanking to the TSS divided by size and read count in the same gene body divided by size of the gene body.
Statistical analysis
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